Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

A coagulant-flocculant mixture, a method of making such a coagulant-flocculant mixture, and a method of using such a coagulant-flocculant mixture for treating effluent containing particles within an aqueous medium to facilitate separating the particles and the aqueous medium, whereby the coagulant-flocculant mixture includes an amount of coagulant combined with an amount of flocculant.

A surface treatment liquid which adhesiveness of a component that achieves a surface treatment effect is good, and a desired surface treatment effect is easily obtained, and a surface treatment method using the surface treatment liquid are provided.

A surface treatment liquid including a resin (A) and a solvent (S), in which the resin (A) includes a constituent unit (a1) derived form a compound having a hydrophilic group and an ethylenic double bond and a constituent unit (a2) derived from a compound a nitrogen-containing heterocyclic group, an ethylenic double bond, and a specific type of polar group is used.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.

A preparation method of a powdery polycarboxylate superplasticizer is provided, including: mixing a superplasticizer monomer with water to produce a mixture, heating and melting the mixture to produce a melt system; carrying out a bulk polymerization reaction by adding an initiator, a chain transfer agent and an unsaturated carboxylic acid into the melt system, forming a polycarboxylate superplasticizer precursor; and neutralizing and pulverizing the polycarboxylate superplasticizer precursor to produce a powdery polycarboxylate superplasticizer. Water is added in the bulk polymerization and reacts with the superplasticizer monomer and the unsaturated carboxylic acid. While the bulk polymerization reaction is guaranteed to be efficiently carried out and the solid polycarboxylate superplasticizer is formed, the viscosity of a bulk polymerization reaction system is reduced. The superplasticizer is suitable for dry-mixed mortar, high-efficiency concrete and other products.

A preparation method of a powdery polycarboxylate superplasticizer is provided, including: mixing a superplasticizer monomer with water to produce a mixture, heating and melting the mixture to produce a melt system; carrying out a bulk polymerization reaction by adding an initiator, a chain transfer agent and an unsaturated carboxylic acid into the melt system, forming a polycarboxylate superplasticizer precursor; and neutralizing and pulverizing the polycarboxylate superplasticizer precursor to produce a powdery polycarboxylate superplasticizer. Water is added in the bulk polymerization and reacts with the superplasticizer monomer and the unsaturated carboxylic acid. While the bulk polymerization reaction is guaranteed to be efficiently carried out and the solid polycarboxylate superplasticizer is formed, the viscosity of a bulk polymerization reaction system is reduced. The superplasticizer is suitable for dry-mixed mortar, high-efficiency concrete and other products.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

A fiber treatment agent can provide artificial hair fiber with softness. The fiber treatment agent includes a cationic polymer having a structural unit derived from diallyldimethylammonium chloride (DADMAC), and content of the cationic polymer is 0.02 to 0.5 weight %. The cationic polymer preferably has a structural unit derived from acrylamide. Preferably, the fiber treatment agent further includes an antistatic agent, and content of the antistatic agent is 0.2 to 5.0 weight %.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.